| Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease C De Hemptinne, NC Swann, JL Ostrem, ES Ryapolova-Webb, ... Nature neuroscience 18 (5), 779-786, 2015 | 639 | 2015 |
| Mutations in GNAL cause primary torsion dystonia T Fuchs, R Saunders-Pullman, I Masuho, MS Luciano, D Raymond, ... Nature genetics 45 (1), 88-92, 2013 | 335 | 2013 |
| Gamma oscillations in the hyperkinetic state detected with chronic human brain recordings in Parkinson's disease NC Swann, C De Hemptinne, S Miocinovic, S Qasim, SS Wang, N Ziman, ... Journal of Neuroscience 36 (24), 6445-6458, 2016 | 293 | 2016 |
| Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson’s disease R Gilron, S Little, R Perrone, R Wilt, C de Hemptinne, MS Yaroshinsky, ... Nature biotechnology 39 (9), 1078-1085, 2021 | 214 | 2021 |
| Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson’s disease JL Ostrem, N Ziman, NB Galifianakis, PA Starr, M San Luciano, M Katz, ... Journal of neurosurgery 124 (4), 908-916, 2016 | 165 | 2016 |
| Pallidal deep-brain stimulation disrupts pallidal beta oscillations and coherence with primary motor cortex in Parkinson's disease DD Wang, C de Hemptinne, S Miocinovic, JL Ostrem, NB Galifianakis, ... Journal of Neuroscience 38 (19), 4556-4568, 2018 | 145 | 2018 |
| Chronic multisite brain recordings from a totally implantable bidirectional neural interface: experience in 5 patients with Parkinson's disease NC Swann, C De Hemptinne, S Miocinovic, S Qasim, JL Ostrem, ... Journal of neurosurgery 128 (2), 605-616, 2017 | 143 | 2017 |
| Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations RN Alcalay, A Mirelman, R Saunders‐Pullman, MX Tang, ... Movement Disorders 28 (14), 1966-1971, 2013 | 140 | 2013 |
| Caregiver burden in epilepsy: determinants and impact I Karakis, AJ Cole, GD Montouris, M San Luciano, KJ Meador, ... Epilepsy research and treatment 2014 (1), 808421, 2014 | 125 | 2014 |
| Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis I Agalliu, M San Luciano, A Mirelman, N Giladi, B Waro, J Aasly, ... JAMA neurology 72 (1), 58-65, 2015 | 124 | 2015 |
| Subthalamic nucleus deep brain stimulation in isolated dystonia: a 3-year follow-up study JL Ostrem, M San Luciano, KA Dodenhoff, N Ziman, LC Markun, ... Neurology 88 (1), 25-35, 2017 | 121 | 2017 |
| Digitized spiral drawing: A possible biomarker for early Parkinson’s disease M San Luciano, C Wang, RA Ortega, Q Yu, S Boschung, J Soto-Valencia, ... PloS one 11 (10), e0162799, 2016 | 108 | 2016 |
| Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites R Saunders-Pullman, D Raymond, AJ Stoessl, D Hobson, T Nakamura, ... Neurology 78 (9), 649-657, 2012 | 107 | 2012 |
| Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind … JL Vitek, R Jain, L Chen, AI Tröster, LE Schrock, PA House, ML Giroux, ... The Lancet Neurology 19 (6), 491-501, 2020 | 105 | 2020 |
| Subthalamic local field potentials in Parkinson's disease and isolated dystonia: an evaluation of potential biomarkers DD Wang, C de Hemptinne, S Miocinovic, SE Qasim, AM Miller, ... Neurobiology of disease 89, 213-222, 2016 | 101 | 2016 |
| Patient and caregiver quality of life in psychogenic non-epileptic seizures compared to epileptic seizures I Karakis, GD Montouris, C Piperidou, M San Luciano, KJ Meador, ... Seizure 23 (1), 47-54, 2014 | 100 | 2014 |
| LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease R Saunders‐Pullman, MJ Barrett, KM Stanley, MS Luciano, V Shanker, ... Movement Disorders 25 (15), 2536-2541, 2010 | 95 | 2010 |
| Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease M Katz, MS Luciano, K Carlson, P Luo, WJ Marks Jr, PS Larson, PA Starr, ... Annals of neurology 77 (4), 710-719, 2015 | 80 | 2015 |
| Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation A Mirelman, T Heman, K Yasinovsky, A Thaler, T Gurevich, K Marder, ... Movement Disorders 28 (12), 1683-1690, 2013 | 80 | 2013 |
| Substance abuse and movement disorders: complex interactions and comorbidities A Deik, R Saunders-Pullman, M San Luciano Current drug abuse reviews 5 (3), 243-253, 2012 | 78 | 2012 |
